Citizen Health just locked in a $30M Series A, and if you’re not paying attention to what’s happening in the rare disease space, you’re already behind.
This isn’t your standard healthtech headline. This is Farid Vij and Nasha Fitter turning personal pain into precision infrastructure. If their names sound familiar, it’s because they are. Farid Vij co-founded the original Citizen, which got snapped up by Invitae in 2021. Now, with Citizen Health, he and Nasha Fitter, whose fight for better care started at home, not in some lab, are building the platform they wish existed when it mattered most.
The AI Advocate they’re rolling out isn’t some gimmicky chatbot tossing out medical trivia. This is a personalized engine trained on your health records, your symptoms, your data, and yes, your community. It reads longitudinal trends like a market analyst with a grudge, cross-checks them against community wisdom, and hands patients actionable steps before the system even knows what hit it.
It’s not about more data. It’s about turning fragmented histories into full-context futures. There are 400 million people worldwide stuck in the diagnostic shadows of rare disease. With 95% of those conditions lacking FDA-approved treatment, these patients aren’t waiting for a fix, they’re building one.
And the investors? Heavy hitters showed up for this one. 8VC led the round with surgical precision, joined by Transformation Capital and Headline. The same Transformation Capital that led the $14.5M Seed in December 2023, with Wavemaker 360 and the Chan Zuckerberg Initiative also in the mix. Total war chest? $44.5M and counting.
But money’s just the marker. What matters is impact. Citizen Health already has 60 active patient communities spanning 123 conditions, and 70+ advocacy group partners, most of whom joined without being asked. Voluntary data sharing sits at 98.3%, and the kicker? The FDA’s already accepting that data in regulatory submissions. That’s not potential. That’s infrastructure.
And it’s moving fast. The first release of the AI Advocate hits in Q3 2025, starting with pilot communities. After that? Deeper care-navigation tools, research integrations, and a serious playbook for patient advocacy organizations. All built from the ground up with compliance, consent, and real-world outcomes baked in.
Farid Vij and Nasha Fitter aren’t chasing hype; they’re shifting gravity. And with 10+ pharma partnerships already in play and a U.S.-first rollout underway, Citizen Health isn’t just joining the rare disease conversation. They’re owning the mic.
